Log in
Enquire now
‌

US Patent 11339144 Heteroaryl Rheb inhibitors and uses thereof

Patent 11339144 was granted and assigned to Navitor Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Navitor Pharmaceuticals
Navitor Pharmaceuticals
Current Assignee
Navitor Pharmaceuticals
Navitor Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11339144
Date of Patent
May 24, 2022
Patent Application Number
16604208
Date Filed
April 9, 2018
Patent Primary Examiner
‌
Valerie Rodriguez-Garcia
CPC Code
‌
C07D 209/42
Patent abstract

The present invention provides compounds of general Formula I and I′:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11339144 Heteroaryl Rheb inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.